Roz joined Pfizer in 2006 and is Pfizer’s Global Patient Affairs Lead in the Chief Medical Office. Roz’s team drives the more systematic integration of preferences and experiences of people living with illness throughout the lifecycle of medicines and their development. She has held other leadership roles in Medical Affairs, Medical Strategy and Medicine Development at Pfizer.
Roz received her Bachelor of Science from the Sophie Davis School of Biomedical Education of the City College of New York, MD from Mount Sinai School of Medicine, and later her MSc in Pharmaceutical Medicine from Hibernia College.
Roz is a retired Clinical Professor of Medicine of Albert Einstein College of Medicine, is an Internist, Pulmonologist, Intensivist, and cared for patients at Beth Israel Medical Center, NY, for twenty years. She presented and published primarily in the areas of pulmonary complications of HIV infection, venous thromboembolic disease, medical ethics and medical education. She is a fellow of both the American College of Physicians and the American College of Chest Physicians.
To be the premier, innovative biopharmaceutical companyPfizer’s purpose is to innovate to bring therapies and vaccines that significantly improve peoples' lives.
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action - Article
12 Jan 2018
Roslyn Schneider, Global Patients’ Affairs Lead at Pfizer, on Patient Engagement - Video
12 Jan 2018
Patient Engagement and Involvement in Research and Development
12 Apr 2018
Global Patient Affairs Lead, Pfizer Medical
I commit to working with the patient community on where, when and how their involvement with industry is most productive and appropriate for them as our collective experience evolves.Work in progress